18 min listen
Purdue Pharma's 'one-two' punch
FromBehind the Money
ratings:
Length:
21 minutes
Released:
Sep 11, 2018
Format:
Podcast episode
Description
The name “Sackler” adorns museums and art galleries around the world. But the family name has also become tainted by its association with the US opioid crisis, amid accusations that OxyContin, more than any other drug, is responsible for sparking one of the worst public health epidemics of modern times. The FT's David Crow explains how the Sackler family company Purdue Pharma got its hold on the opioid market. For information regarding your data privacy, visit acast.com/privacy
Released:
Sep 11, 2018
Format:
Podcast episode
Titles in the series (100)
How beauty is beating the rest of retail: Record numbers of bankruptcies and store closures have devastated the retail sector. So why is the beauty market thriving? Will the likes of Sephora and Ulta be able to ward off Amazon? With guests Moj Mahdara, chief executive of Beautycon, and&nbs... by Behind the Money